Oswald Clark: On August 16, the Fifth Circuit Court of Appeals ruled against the Food and Drug Administration’s relaxation of restrictions around the abortion pill mifepristone in 2016, 2019, and 2021, saying they did not take into consideration the health and safety of women. The decision will likely be stayed until the Supreme Court hears the case; the Biden administration’s Justice Department […]
You are unauthorized to view this entire article. Please log in to your account to receive full access to The Interim.
